1. Home
  2. AVBP vs CTBI Comparison

AVBP vs CTBI Comparison

Compare AVBP & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • CTBI
  • Stock Information
  • Founded
  • AVBP 2021
  • CTBI 1903
  • Country
  • AVBP United States
  • CTBI United States
  • Employees
  • AVBP N/A
  • CTBI N/A
  • Industry
  • AVBP
  • CTBI Major Banks
  • Sector
  • AVBP
  • CTBI Finance
  • Exchange
  • AVBP NYSE
  • CTBI Nasdaq
  • Market Cap
  • AVBP 948.5M
  • CTBI 888.9M
  • IPO Year
  • AVBP 2024
  • CTBI N/A
  • Fundamental
  • Price
  • AVBP $27.45
  • CTBI $59.68
  • Analyst Decision
  • AVBP Strong Buy
  • CTBI Strong Buy
  • Analyst Count
  • AVBP 5
  • CTBI 3
  • Target Price
  • AVBP $36.80
  • CTBI $55.50
  • AVG Volume (30 Days)
  • AVBP 146.0K
  • CTBI 60.6K
  • Earning Date
  • AVBP 11-13-2024
  • CTBI 01-15-2025
  • Dividend Yield
  • AVBP N/A
  • CTBI 3.15%
  • EPS Growth
  • AVBP N/A
  • CTBI N/A
  • EPS
  • AVBP N/A
  • CTBI 4.40
  • Revenue
  • AVBP N/A
  • CTBI $226,756,000.00
  • Revenue This Year
  • AVBP N/A
  • CTBI N/A
  • Revenue Next Year
  • AVBP N/A
  • CTBI $6.05
  • P/E Ratio
  • AVBP N/A
  • CTBI $13.56
  • Revenue Growth
  • AVBP N/A
  • CTBI 0.62
  • 52 Week Low
  • AVBP $14.35
  • CTBI $38.44
  • 52 Week High
  • AVBP $36.37
  • CTBI $61.60
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 41.86
  • CTBI 64.21
  • Support Level
  • AVBP $33.17
  • CTBI $56.68
  • Resistance Level
  • AVBP $28.82
  • CTBI $61.60
  • Average True Range (ATR)
  • AVBP 1.99
  • CTBI 2.41
  • MACD
  • AVBP -0.81
  • CTBI -0.07
  • Stochastic Oscillator
  • AVBP 16.79
  • CTBI 80.21

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: